PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Network Science Institute, Northeastern University, Boston, MA 02115.\', \'Department of Physics, Northeastern University, Boston, MA 02115.\', \'Channing Division of Network Medicine, Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA 02115.\', \'Department of Biomedical Informatics, Harvard University, Boston, MA 02115.\', \'Harvard Data Science Initiative, Harvard University, Cambridge, MA 02138.\', \'Data Science Department, Scipher Medicine, Waltham, MA 02453.\', \'Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul 34956, Turkey.\', \'Department of Microbiology, National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118.\', \'Department of Medicine, Brigham and Women\'s Hospital, Harvard Medical School, Boston, MA 02115.\', \'Network Science Institute, Northeastern University, Boston, MA 02115; a.barabasi@northeastern.edu.\', \'Department of Network and Data Science, Central European University, Budapest 1051, Hungary.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e202558111810.1073/pnas.2025581118
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 33906951
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
is ?:relation_isRelatedTo_publication of
?:title
  • Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all